Alpha Tau Issues Letter to Shareholders: Five Concurrent Trials in the U.S. with Multiple Significant Value-Driving Milestones Ahead
Taiho Oncology Appoints Peter Melnyk as President & Chief Executive Officer [Yahoo! Finance]
Alpha Tau Medical: Pancreatic, GBM, And Other Updates; Set Up For A Strong, Catalyst-Rich 2026 [Seeking Alpha]
Alpha Tau Medical (NASDAQ:DRTS) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Wall Street Breakfast Podcast: Selloff To Surge In Defense [Seeking Alpha]